Nurix Therapeutics (NRIX) Free Cash Flow Growth (5y) (2024 - 2026)
Nurix Therapeutics (NRIX) Free Cash Flow Growth (5y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Nurix Therapeutics | 2.65 Bn | 2.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -25.61% |
| Feb 28, 2026 | -64.95% |
| Nov 30, 2025 | -25.62% |
| Aug 31, 2025 | -49.55% |
| May 31, 2025 | -30.52% |
| Feb 28, 2025 | -29.13% |
| Nov 30, 2024 | -24.72% |